Pharmacy Can't Dodge Novo Nordisk's Diabetes Drug Suit

By Mike Curley · August 15, 2024, 7:18 PM EDT

A Tennessee federal judge on Thursday declined to throw out a suit by Novo Nordisk Inc. alleging that DCA Pharmacy is selling drugs with the same active ingredient as its Ozempic...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum

Case Information

Case Title

Novo Nordisk Inc. v. DCA Pharmacy

Case Number

Court

Tennessee Middle

Nature of Suit

Personal Property: Other

Date Filed

July 06, 2023

Recent Articles By Mike

October 11, 2024
Texan Who Sued Ex's Colleagues Over Abortion Drops Suit
October 09, 2024
Patients' Families Say No Expert Needed In Transplant Case
October 09, 2024
Philips Preserves Lanham Act Counterclaim In CPAP Cleaner MDL
October 09, 2024
Companies' Kratom Supplements Are Addictive, Class Says
September 26, 2024
Winner Of $8.6M Suit Wants Mich. Justices' Take On Cap
September 20, 2024
Expert Witness's Change Of Tune Dooms Mich. Med Mal Suit
September 03, 2024
Glenmark Hit With $50M Suit Over Potassium Pill Death
August 20, 2024
Fed Circ. Finds No Fault In Denial Of Flu Vaccine Claim
August 14, 2024
Florida AG Can't Nix Hospitals', School Boards' Opioid Claims
August 02, 2024
6th Circ. Upholds Federal Hospital's Win In Infant Death Suit